Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Post by JayjayUSA12007on Jun 21, 2018 12:20am

331 Views

Post# 28203558

Thera convertible debenture trading activities

Today 06/20/2018, trading volume of T.TH.DB.U symbol for this convert was at 1,373,000 unit @ $99.xx/ a piece ? (link: https://www.stockhouse.com/companies/quote/t.th.db.u/theratechnologies )
That is almost $137,000,000 Canadian !!!! More than 10 times trading value of the underlying security.

Bullboard Posts

What will the U.S. election results mean for Canada?